Persistent Hypoxemia and Biomarkers in Severe COVID-19 Pneumonia Patients Treated with Methylprednisolone
Ronaldo C. Go,
Alexander P. Stoffan,
Themba Nyirenda
Abstract:Despite corticosteroids, biomarkers, SpO2/FiO2, and racial/ethnic groups have been associated with mortality in Severe COVID-19 Pneumonia. This is a secondary analysis of a cohort study of adults admitted from March to June 2020 in 13 hospitals in New Jersey, United States who received methylprednisolone. Out of 380 patients, those with persistent hypoxemia (SpO2/FiO2 < 315 on day 1 and day 7), mortality was 86 patients (43%) with an in-hospital-survival median 31 days [IQR: 22–48 days] whereas those withou… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.